AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,42 USD
arrow_downward
-1,57%(-0,47) 1D
18-ноя., 13:06:59 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,57 USD
High
30,48 USD
Low
29,22 USD
Mkt. cap
1,76 млд
Avg. vol.
1,21 млн
Volume
107,21 миң
52-wk high
44,07 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
29,57 USD
High
30,48 USD
Low
29,22 USD
Mkt. cap
1,76 млд
Avg. vol.
1,21 млн
Volume
107,21 миң
52-wk high
44,07 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
24/7 Wall St.
·
1 саат мурун
S&P 500 Slides 0.6% at Midday as the Dow Drops Over 1%
TradingView
·
2 саат мурун
S&P 500, Nasdaq find footing as Nvidia treads water
ChartMill
·
2 саат мурун
S&P 500 Gap-Down Movers for Nov. 18 Session
JournalArta
·
1 саат мурун
S&P 500 Futures Rise After Nvidia Raises Sales Forecast
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc